The decision by the US to designate Nigeria as a "Country of Particular Concern for Religious Freedom" is a matter for the Governments of Nigeria and the US.<\/p>
The UK is committed to promoting and protecting the right to freedom of religion or belief around the world. We are a strong voice internationally in defence of this fundamental right and promoting respect between communities of different religions and those of no religion. Nigeria is a secular state and the right to freedom of religion or belief is protected by the constitution. In Nigeria we engage with a range of faith-based communities and support inter-faith peacebuilding and dialogue. We continue to encourage the Nigerian Government to take urgent action to protect those at risk of violence, to bring perpetrators to justice, and to implement long-term solutions that address the root causes of violence and meet the needs of all communities.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4210", "label" : {"_value" : "Biography information for Lord Ahmad of Wimbledon"} } , "answeringMemberPrinted" : {"_value" : "Lord Ahmad of Wimbledon"} , "dateOfAnswer" : {"_value" : "2020-12-23", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2020-12-23T15:51:49.253Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "208"} , "answeringDeptShortName" : {"_value" : "Foreign, Commonwealth and Development Office"} , "answeringDeptSortName" : {"_value" : "Foreign, Commonwealth and Development Office"} , "date" : {"_value" : "2020-12-09", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Nigeria: Religious Freedom"} , "houseId" : {"_value" : "2"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"} } ], "questionText" : "To ask Her Majesty's Government what assessment they have made of the re-designation of Nigeria as a Country of Particular Concern by the government of the United States; and whether they intend to take similar steps.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/738", "label" : {"_value" : "Biography information for Lord Alton of Liverpool"} } , "tablingMemberPrinted" : [{"_value" : "Lord Alton of Liverpool"} ], "uin" : "HL11262"} , {"_about" : "http://data.parliament.uk/resources/1259911", "AnsweringBody" : [{"_value" : "Foreign, Commonwealth and Development Office"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1259911/answer", "answerText" : {"_value" : "
We are aware of reports of arrests near Afrin in north-west Syria. Ministers and officials regularly discuss the situation in Syria with the Government of Turkey. In those discussions we make clear the importance of all parties to the Syrian conflict abiding by their obligations under international law. We have not raised the specific report of arrests near Afrin or made any assessment of the welfare of those detained.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4210", "label" : {"_value" : "Biography information for Lord Ahmad of Wimbledon"} } , "answeringMemberPrinted" : {"_value" : "Lord Ahmad of Wimbledon"} , "dateOfAnswer" : {"_value" : "2020-12-23", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2020-12-23T16:23:39.56Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "208"} , "answeringDeptShortName" : {"_value" : "Foreign, Commonwealth and Development Office"} , "answeringDeptSortName" : {"_value" : "Foreign, Commonwealth and Development Office"} , "date" : {"_value" : "2020-12-09", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Syria: Yazidis"} , "houseId" : {"_value" : "2"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"} } ], "questionText" : "To ask Her Majesty's Government what assessment they have made of reports of arrests by Faylaq Al-Sham of people in Yazidi villages near Afrin in northwest Syria on 4 December; what assessment they have made of the wellbeing of those who have been arrested; and what representations they have made to the government of Turkey about (1) the release of any such people, and (2) the protection of Yazidis in Afrin.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/738", "label" : {"_value" : "Biography information for Lord Alton of Liverpool"} } , "tablingMemberPrinted" : [{"_value" : "Lord Alton of Liverpool"} ], "uin" : "HL11263"} , {"_about" : "http://data.parliament.uk/resources/1259912", "AnsweringBody" : [{"_value" : "Foreign, Commonwealth and Development Office"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1259912/answer", "answerText" : {"_value" : "
We are in close contact with a wide range of businesses in Hong Kong, but it is for businesses themselves to make their own judgement calls. We are concerned that a number of recent decisions by the authorities in Hong Kong are further evidence of a determined campaign to stifle opposition and silence dissent. As a signatory to the Sino-British Joint Declaration, China must abide by the legally binding commitments it made to uphold fundamental rights and freedoms, and respect Hong Kong's high degree of autonomy for at least 50 years from 1997. The UK will continue to pursue an approach in Hong Kong that is rooted in our values, defends the rights of the people of Hong Kong and respects the provisions of the Joint Declaration.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4210", "label" : {"_value" : "Biography information for Lord Ahmad of Wimbledon"} } , "answeringMemberPrinted" : {"_value" : "Lord Ahmad of Wimbledon"} , "dateOfAnswer" : {"_value" : "2020-12-23", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2020-12-23T16:24:59.4Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "208"} , "answeringDeptShortName" : {"_value" : "Foreign, Commonwealth and Development Office"} , "answeringDeptSortName" : {"_value" : "Foreign, Commonwealth and Development Office"} , "date" : {"_value" : "2020-12-09", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Hong Kong: HSBC"} , "houseId" : {"_value" : "2"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"} } ], "questionText" : "To ask Her Majesty's Government what assessment they have made of reports that HSBC has frozen the bank accounts of (1) the Good Neighbourhood North District Church in Hong Kong, and (2) its pastor and his wife; and what assessment they have made of whether such action has been taken because of that Church\u2019s links with pro-democracy campaigners in Hong Kong.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/738", "label" : {"_value" : "Biography information for Lord Alton of Liverpool"} } , "tablingMemberPrinted" : [{"_value" : "Lord Alton of Liverpool"} ], "uin" : "HL11264"} , {"_about" : "http://data.parliament.uk/resources/1259913", "AnsweringBody" : [{"_value" : "Foreign, Commonwealth and Development Office"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1259913/answer", "answerText" : {"_value" : "
The Government of Ethiopia indicated on 8 December that it would conduct the initial investigation into the reported killing of civilians on 9 November in Mai Kadra. Since 8 December, we have spoken with representatives of the Government of Ethiopia about the nature of that investigation and to make clear that HMG supports the call by the Ethiopian Commission for Human Rights for the independent investigation of human rights abuses and violations.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4210", "label" : {"_value" : "Biography information for Lord Ahmad of Wimbledon"} } , "answeringMemberPrinted" : {"_value" : "Lord Ahmad of Wimbledon"} , "dateOfAnswer" : {"_value" : "2020-12-23", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2020-12-23T15:48:31.2Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "208"} , "answeringDeptShortName" : {"_value" : "Foreign, Commonwealth and Development Office"} , "answeringDeptSortName" : {"_value" : "Foreign, Commonwealth and Development Office"} , "date" : {"_value" : "2020-12-09", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Ethiopia: Genocide"} , "houseId" : {"_value" : "2"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"} } ], "questionText" : "To ask Her Majesty's Government what representations they have made to the government of Ethiopia about reports that it has refused the offer of international co-operation in investigating the Mai Kadra massacre; if they have, what response they received; and, if not, whether they intend to make representations.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/738", "label" : {"_value" : "Biography information for Lord Alton of Liverpool"} } , "tablingMemberPrinted" : [{"_value" : "Lord Alton of Liverpool"} ], "uin" : "HL11265"} , {"_about" : "http://data.parliament.uk/resources/1259916", "AnsweringBody" : [{"_value" : "Department for Education"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1259916/answer", "answerText" : {"_value" : "
The Government recently outlined reforms which aim to increase the take-up of high-quality higher technical qualifications. We have introduced a new approval scheme to show which higher technical qualifications meet employers\u2019 skills needs, and we will support providers in this area and improve information, advice, and guidance for learners and employers alike.<\/p>
Table 1, attached, details management information from the Student Loans Company (SLC) on the average value of loans taken out by 18 to 24-year-old students (as of 1 September in the relevant year) studying for a Higher National Certificate (HNC) or Higher National Diploma (HND). It covers the academic years 2017/18, 2018/19, and 2019/20 for English-domiciled students studying in the UK and EU-domiciled students studying in England.<\/p>
Students are around four months into the 2020/21 academic year; as such, the number of students and average loan amounts are subject to change. Comparable figures for 2020/21 will be available after the end of the academic year.<\/p>
The figures in Table 1 have been rounded to the nearest pound.<\/p>
Table 2, attached, details SLC management information on the number of 18 to 24-year-old students in receipt of a loan (broken down by tuition fee loan and maintenance loan) and studying for a HNC or HND. It covers the academic years 2017/18, 2018/19, and 2019/20 for English-domiciled students studying in the UK and EU-domiciled students studying in England.<\/p>
Students may take out a maintenance loan, a tuition fee loan, or both. Therefore, the average overall loan per academic year for HNCs or HNDs will not be the sum of the average loan for each product. Similarly, the total number of students taking out loans for HNCs or HNDs is not equal to the number in receipt of each loan product.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4728", "label" : {"_value" : "Biography information for Lord Parkinson of Whitley Bay"} } , "answeringMemberPrinted" : {"_value" : "Lord Parkinson of Whitley Bay"} , "attachment" : {"_about" : "http://data.parliament.uk/resources/1259916/answer/attachment/1", "fileName" : {"_value" : "HL11268 and HL11269 tables showing loans taken out by students studying Higher National Certificate or Higher National Diploma.pdf"} , "title" : "HL11268_HL11269_table"} , "dateOfAnswer" : {"_value" : "2020-12-18", "_datatype" : "dateTime"} , "groupedQuestionUIN" : {"_value" : "HL11269"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2020-12-18T14:26:44.923Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "60"} , "answeringDeptShortName" : {"_value" : "Education"} , "answeringDeptSortName" : {"_value" : "Education"} , "date" : {"_value" : "2020-12-09", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Students: Loans"} , "houseId" : {"_value" : "2"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"} } ], "questionText" : "To ask Her Majesty's Government how many loans were taken out by students aged between 18 and 24 studying for (1) Higher National Certificates, and (2) Higher National Diplomas, for the years (a) 2017, (b) 2018, (c) 2019 and (d) 2020; and how many of these students also took out maintenance loans.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/1028", "label" : {"_value" : "Biography information for Lord Baker of Dorking"} } , "tablingMemberPrinted" : [{"_value" : "Lord Baker of Dorking"} ], "uin" : "HL11268"} , {"_about" : "http://data.parliament.uk/resources/1259918", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1259918/answer", "answerText" : {"_value" : "
To date the Medicines and Healthcare products Regulatory Agency (MHRA), as well as independent expert advisors on the Commission on Human Medicines and its Expert Working Groups, have completed the assessment of the quality, safety and efficacy data only for the Pfizer/BioNTech vaccine. This vaccine is an mRNA vaccine and data supported a two dose regimen. Efficacy was evaluated in terms of prevention of COVID-19 caused by the SARS-CoV-2 virus, in terms of vulnerability to COVID-19 of the person vaccinated. Clinical trial data showed that, compared to the placebo, efficacy of the Pfizer/BioNTech vaccine from first COVID-19 occurrence from seven days after dose two in participants with or without evidence of prior infection with SARS-CoV-2 was 94.6% - a 95% credible interval of 89.9% to 97.3%).<\/p>
There is currently no data available regarding transmission of COVID-19 to others in a person who has been vaccinated using any of the COVID-19 vaccines. There is also currently no data available for any COVID-19 vaccine on the period after vaccination for which a person can remain asymptomatic.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4708", "label" : {"_value" : "Biography information for Lord Bethell"} } , "answeringMemberPrinted" : {"_value" : "Lord Bethell"} , "dateOfAnswer" : {"_value" : "2020-12-17", "_datatype" : "dateTime"} , "groupedQuestionUIN" : [{"_value" : "HL11196"} , {"_value" : "HL11197"} , {"_value" : "HL11198"} , {"_value" : "HL11199"} , {"_value" : "HL11279"} , {"_value" : "HL11280"} , {"_value" : "HL11281"} ], "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2020-12-17T13:44:06.647Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2020-12-09", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Coronavirus: Vaccination"} , "houseId" : {"_value" : "2"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"} } ], "questionText" : "To ask Her Majesty's Government what was the incidence of vaccinated people being able to pass on COVID-19 to those who have not been vaccinated in the trial COVID-19 vaccination programmes.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/499", "label" : {"_value" : "Biography information for Lord Campbell-Savours"} } , "tablingMemberPrinted" : [{"_value" : "Lord Campbell-Savours"} ], "uin" : "HL11278"} , {"_about" : "http://data.parliament.uk/resources/1259919", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1259919/answer", "answerText" : {"_value" : "
To date the Medicines and Healthcare products Regulatory Agency (MHRA), as well as independent expert advisors on the Commission on Human Medicines and its Expert Working Groups, have completed the assessment of the quality, safety and efficacy data only for the Pfizer/BioNTech vaccine. This vaccine is an mRNA vaccine and data supported a two dose regimen. Efficacy was evaluated in terms of prevention of COVID-19 caused by the SARS-CoV-2 virus, in terms of vulnerability to COVID-19 of the person vaccinated. Clinical trial data showed that, compared to the placebo, efficacy of the Pfizer/BioNTech vaccine from first COVID-19 occurrence from seven days after dose two in participants with or without evidence of prior infection with SARS-CoV-2 was 94.6% - a 95% credible interval of 89.9% to 97.3%).<\/p>
There is currently no data available regarding transmission of COVID-19 to others in a person who has been vaccinated using any of the COVID-19 vaccines. There is also currently no data available for any COVID-19 vaccine on the period after vaccination for which a person can remain asymptomatic.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4708", "label" : {"_value" : "Biography information for Lord Bethell"} } , "answeringMemberPrinted" : {"_value" : "Lord Bethell"} , "dateOfAnswer" : {"_value" : "2020-12-17", "_datatype" : "dateTime"} , "groupedQuestionUIN" : [{"_value" : "HL11196"} , {"_value" : "HL11197"} , {"_value" : "HL11198"} , {"_value" : "HL11199"} , {"_value" : "HL11278"} , {"_value" : "HL11280"} , {"_value" : "HL11281"} ], "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2020-12-17T13:44:06.957Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2020-12-09", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Coronavirus: Vaccination"} , "houseId" : {"_value" : "2"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"} } ], "questionText" : "To ask Her Majesty's Government for how long a person who has received the two-doses of the COVID-19 vaccine required under the vaccination protocols can remain asymptomatic.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/499", "label" : {"_value" : "Biography information for Lord Campbell-Savours"} } , "tablingMemberPrinted" : [{"_value" : "Lord Campbell-Savours"} ], "uin" : "HL11279"} , {"_about" : "http://data.parliament.uk/resources/1259920", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1259920/answer", "answerText" : {"_value" : "
To date the Medicines and Healthcare products Regulatory Agency (MHRA), as well as independent expert advisors on the Commission on Human Medicines and its Expert Working Groups, have completed the assessment of the quality, safety and efficacy data only for the Pfizer/BioNTech vaccine. This vaccine is an mRNA vaccine and data supported a two dose regimen. Efficacy was evaluated in terms of prevention of COVID-19 caused by the SARS-CoV-2 virus, in terms of vulnerability to COVID-19 of the person vaccinated. Clinical trial data showed that, compared to the placebo, efficacy of the Pfizer/BioNTech vaccine from first COVID-19 occurrence from seven days after dose two in participants with or without evidence of prior infection with SARS-CoV-2 was 94.6% - a 95% credible interval of 89.9% to 97.3%).<\/p>
There is currently no data available regarding transmission of COVID-19 to others in a person who has been vaccinated using any of the COVID-19 vaccines. There is also currently no data available for any COVID-19 vaccine on the period after vaccination for which a person can remain asymptomatic.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4708", "label" : {"_value" : "Biography information for Lord Bethell"} } , "answeringMemberPrinted" : {"_value" : "Lord Bethell"} , "dateOfAnswer" : {"_value" : "2020-12-17", "_datatype" : "dateTime"} , "groupedQuestionUIN" : [{"_value" : "HL11196"} , {"_value" : "HL11197"} , {"_value" : "HL11198"} , {"_value" : "HL11199"} , {"_value" : "HL11278"} , {"_value" : "HL11279"} , {"_value" : "HL11281"} ], "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2020-12-17T13:44:07.02Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2020-12-09", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Coronavirus: Vaccination"} , "houseId" : {"_value" : "2"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"} } ], "questionText" : "To ask Her Majesty's Government what assessment they have made of whether a person who has been vaccinated against COVID-19 can acquire COVID-19 asymptomatic status without indicators and transmit the virus on to another person who has not been vaccinated.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/499", "label" : {"_value" : "Biography information for Lord Campbell-Savours"} } , "tablingMemberPrinted" : [{"_value" : "Lord Campbell-Savours"} ], "uin" : "HL11280"} , {"_about" : "http://data.parliament.uk/resources/1259921", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1259921/answer", "answerText" : {"_value" : "
To date the Medicines and Healthcare products Regulatory Agency (MHRA), as well as independent expert advisors on the Commission on Human Medicines and its Expert Working Groups, have completed the assessment of the quality, safety and efficacy data only for the Pfizer/BioNTech vaccine. This vaccine is an mRNA vaccine and data supported a two dose regimen. Efficacy was evaluated in terms of prevention of COVID-19 caused by the SARS-CoV-2 virus, in terms of vulnerability to COVID-19 of the person vaccinated. Clinical trial data showed that, compared to the placebo, efficacy of the Pfizer/BioNTech vaccine from first COVID-19 occurrence from seven days after dose two in participants with or without evidence of prior infection with SARS-CoV-2 was 94.6% - a 95% credible interval of 89.9% to 97.3%).<\/p>
There is currently no data available regarding transmission of COVID-19 to others in a person who has been vaccinated using any of the COVID-19 vaccines. There is also currently no data available for any COVID-19 vaccine on the period after vaccination for which a person can remain asymptomatic.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4708", "label" : {"_value" : "Biography information for Lord Bethell"} } , "answeringMemberPrinted" : {"_value" : "Lord Bethell"} , "dateOfAnswer" : {"_value" : "2020-12-17", "_datatype" : "dateTime"} , "groupedQuestionUIN" : [{"_value" : "HL11196"} , {"_value" : "HL11197"} , {"_value" : "HL11198"} , {"_value" : "HL11199"} , {"_value" : "HL11278"} , {"_value" : "HL11279"} , {"_value" : "HL11280"} ], "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2020-12-17T13:44:07.113Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2020-12-09", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Coronavirus: Vaccination"} , "houseId" : {"_value" : "2"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"} } ], "questionText" : "To ask Her Majesty's Government what assessment they have made of whether (1) an adenovirus vector, and (2) an mRNA, COVID-19 vaccine (a) does not prevent a vaccinated person from contracting COVID-19 but suppresses the symptoms of the disease, or (2) prevents a vaccinated person from contracting COVID-19.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/499", "label" : {"_value" : "Biography information for Lord Campbell-Savours"} } , "tablingMemberPrinted" : [{"_value" : "Lord Campbell-Savours"} ], "uin" : "HL11281"} , {"_about" : "http://data.parliament.uk/resources/1259922", "AnsweringBody" : [{"_value" : "Home Office"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1259922/answer", "answerText" : {"_value" : "
The police are tasked with the critical responsibility for maintaining public order and are operationally independent of Government. They will continue to engage, explain and encourage people to follow the rules during the pandemic, but will enforce where necessary.<\/p>
The Home Office continues to work closely with the police and operational partners to ensure they have the powers, resources and guidance they need.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4311", "label" : {"_value" : "Biography information for Baroness Williams of Trafford"} } , "answeringMemberPrinted" : {"_value" : "Baroness Williams of Trafford"} , "dateOfAnswer" : {"_value" : "2020-12-23", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2020-12-23T15:46:38.593Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "1"} , "answeringDeptShortName" : {"_value" : "Home Office"} , "answeringDeptSortName" : {"_value" : "Home Office"} , "date" : {"_value" : "2020-12-09", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Public Order: Coronavirus"} , "houseId" : {"_value" : "2"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"} } ], "questionText" : "To ask Her Majesty's Government what steps they are taking to maintain public order during the COVID-19 pandemic.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4184", "label" : {"_value" : "Biography information for Baroness Eaton"} } , "tablingMemberPrinted" : [{"_value" : "Baroness Eaton"} ], "uin" : "HL11289"} ], "itemsPerPage" : 10, "next" : "https://eldaddp.azurewebsites.net/answeredquestions.text?_page=1&min-date=2018-11-19&AnswerDate=2020-12-23&max-questionFirstAnswered.=2020-12-23T16%3A54%3A45.87Z", "page" : 0, "startIndex" : 1, "totalResults" : 62, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]} }